World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
This AI is creating cancer-killing molecules

This AI is creating cancer-killing molecules

by admin | Apr 22, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By CNN – The hunt for cancer-combatting antibodies normally relies upon human lab scientists combing through vast amounts of data. LabGenius’ automated AI robotic system has disrupted that process. Using machine learning, their model has pushed through the human...
US risks losing biotech edge to China, report warns

US risks losing biotech edge to China, report warns

by admin | Apr 21, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Ned Pagliarulo – PharmaVoice – A commission urged the U.S. government to prioritize biotechnology funding and policies to stay ahead of China in fields it argued are vital to national security. The U.S. risks losing a once-decisive edge over China in...
Japan’s big bet on stem-cell therapies might soon pay off with medical breakthroughs

Japan’s big bet on stem-cell therapies might soon pay off with medical breakthroughs

by admin | Apr 18, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Smriti Mallapaty – Nature – Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might be around the corner. Japan is brimming with signs of an approaching medical revolution. Shiny white robots are...
Cell therapy weekly: license granted for the manufacture and supply of synthetic DNA

Cell therapy weekly: license granted for the manufacture and supply of synthetic DNA

by admin | Apr 17, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Kadeja Johnson – RegMedNet – 4basebio PLC has received a Good Manufacturing Practice certification from the UK Medicine and Healthcare Regulatory Agency (London), authorizing the company to supply GMP-grade synthetic DNA as both a starting material and...
The Global Synthetic Biology Conference: San Jose, California | May 5-8, 2025

The Global Synthetic Biology Conference: San Jose, California | May 5-8, 2025

by admin | Apr 15, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

This is where the world’s top innovators, thought leaders, entrepreneurs, and investors come together to build a better world with synthetic biology. Join us in San Jose as we explore how synbio is transforming industries from healthcare, agriculture,...
Molecular Pathways in Bone Marrow Stem Cell Senescence

Molecular Pathways in Bone Marrow Stem Cell Senescence

by admin | Apr 14, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Physician’s Weekly – Researchers conducted a retrospective study to analyze miRNA-mRNA regulatory networks influencing bone marrow mesenchymal stem cell (BMSCs) senescence in age-related osteoporosis (ARO), aiming to determine molecular markers and...
Page 24 of 191« First«...10...2223242526...304050...»Last »

Recent Posts

  • CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission
  • Stem cell therapy linked to lower risk of heart failure after a heart attack
  • Embryo-Like ‘Blood Factories’ Could One Day Supplement Donations
  • Long-Term Growth Hormone Therapy Boosts Pediatric Stem Cells
  • New UCLA drug could restore heart and organ function
  • Parkinson’s treatment tested at UW showing promise in first clinical trial
World Stem Cell Summit Logo - White version
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow